Ablynx Will Announce Half-Year Results For 2009 With Webcast
PharmaLive.com (press release) – Newtown,PA,USA
ALX-0681, a subcutaneous formulation of the novel anti-thrombotic Nanobodies® that also selectively targets von Willebrand factor (vWF) has concluded Phase …